blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3258969

EP3258969 - IMMUNOCONJUGATES FOR SPECIFIC INDUCTION OF T CELL CYTOTOXICITY AGAINST A TARGET CELL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.01.2020
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  15.02.2019
FormerGrant of patent is intended
Status updated on  01.10.2018
FormerExamination is in progress
Status updated on  01.06.2018
FormerRequest for examination was made
Status updated on  24.11.2017
FormerThe international publication has been made
Status updated on  01.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2017/52]
Inventor(s)01 / DZIADEK, Sebastian
Elilandstrasse 2
83671 Benediktbeuern / DE
02 / LIFKE, Alexander
Saalangerstrasse 36
82377 Penzberg / DE
03 / LIFKE, Valeria
Saalangerstrasse 36
82377 Penzberg / DE
04 / HILLRINGHAUS, Lars
Schönrain 9A
82549 Königsdorf-Schönrain / DE
 [2017/52]
Representative(s)Burger, Alexander
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[N/P]
Former [2017/52]Burger, Alexander
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date16705139.017.02.2016
[2017/52]
WO2016EP53332
Priority number, dateEP2015015559818.02.2015         Original published format: EP 15155598
EP2015019930610.12.2015         Original published format: EP 15199306
[2017/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016131856
Date:25.08.2016
Language:EN
[2016/34]
Type: A1 Application with search report 
No.:EP3258969
Date:27.12.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 25.08.2016 takes the place of the publication of the European patent application.
[2017/52]
Type: B1 Patent specification 
No.:EP3258969
Date:20.03.2019
Language:EN
[2019/12]
Search report(s)International search report - published on:EP25.08.2016
ClassificationIPC:A61K47/50
[2017/52]
CPC:
A61K47/6811 (EP,IL,KR,RU,US); A61K47/65 (EP,IL,KR,US); C07K16/2803 (EP,CN,IL,KR,US);
A61K38/08 (IL,RU); A61K47/642 (EP,IL,KR,US); A61K47/6851 (EP,IL,KR,RU,US);
A61P3/10 (EP,IL); A61P31/00 (EP,IL); A61P35/00 (EP,IL,RU);
A61P37/04 (EP,IL); A61P37/08 (EP,IL); A61P43/00 (EP,IL);
C07K16/2818 (EP,CN,IL,KR,US); C07K16/2896 (EP,CN,IL,KR,US); C07K19/00 (IL,RU);
A61K2039/505 (IL,US); A61K2039/507 (EP,CN,IL,KR,US); A61K2039/627 (EP,CN,IL,KR,US);
C07K2317/77 (IL,US); C07K2319/40 (CN,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/52]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:IMMUNKONJUGATE FÜR DIE SPEZIFISCHE INDUKTION VON T-ZELLZYTOTOXIZITÄT GEGEN EINE ZIELZELLE[2017/52]
English:IMMUNOCONJUGATES FOR SPECIFIC INDUCTION OF T CELL CYTOTOXICITY AGAINST A TARGET CELL[2017/52]
French:IMMUNOCONJUGUÉS POUR L'INDUCTION SPÉCIFIQUE DE CYTOTOXICITÉ DES LYMPHOCYTES T CONTRE UNE CELLULE CIBLE[2017/52]
Entry into regional phase18.09.2017National basic fee paid 
18.09.2017Designation fee(s) paid 
18.09.2017Examination fee paid 
Examination procedure19.12.2016Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.06.2017Amendment by applicant (claims and/or description)
19.06.2017Date on which the examining division has become responsible
18.09.2017Examination requested  [2017/52]
04.06.2018Despatch of a communication from the examining division (Time limit: M02)
30.07.2018Reply to a communication from the examining division
02.10.2018Communication of intention to grant the patent
15.01.2019Fee for grant paid
15.01.2019Fee for publishing/printing paid
15.01.2019Receipt of the translation of the claim(s)
Opposition(s)02.01.2020No opposition filed within time limit [2020/09]
Fees paidRenewal fee
07.02.2018Renewal fee patent year 03
08.02.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.02.2016
AL20.03.2019
CY20.03.2019
CZ20.03.2019
DK20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
MC20.03.2019
MK20.03.2019
MT20.03.2019
RS20.03.2019
SI20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
[2022/32]
Former [2022/28]HU17.02.2016
AL20.03.2019
CY20.03.2019
CZ20.03.2019
DK20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
MC20.03.2019
MT20.03.2019
RS20.03.2019
SI20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
Former [2020/50]AL20.03.2019
CZ20.03.2019
DK20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
MC20.03.2019
RS20.03.2019
SI20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
Former [2020/13]AL20.03.2019
CZ20.03.2019
DK20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
SI20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
Former [2020/09]AL20.03.2019
CZ20.03.2019
DK20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
Former [2020/04]AL20.03.2019
CZ20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
IS20.07.2019
PT20.07.2019
Former [2019/51]AL20.03.2019
CZ20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
SK20.03.2019
SM20.03.2019
BG20.06.2019
NO20.06.2019
PT20.07.2019
Former [2019/49]AL20.03.2019
CZ20.03.2019
EE20.03.2019
FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
SK20.03.2019
BG20.06.2019
NO20.06.2019
PT20.07.2019
Former [2019/48]FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
BG20.06.2019
NO20.06.2019
PT20.07.2019
Former [2019/39]FI20.03.2019
HR20.03.2019
LT20.03.2019
LV20.03.2019
RS20.03.2019
BG20.06.2019
NO20.06.2019
Former [2019/38]FI20.03.2019
LT20.03.2019
BG20.06.2019
NO20.06.2019
Former [2019/33]FI20.03.2019
LT20.03.2019
NO20.06.2019
Cited inInternational search[XI]WO9945954  (EPIMMUNE INC [US]);
 [I]WO0012706  (US GOV HEALTH & HUMAN SERV [US], et al);
 [XA]WO2005066203  (AVENTIS PASTEUR INC [US], et al);
 [A]WO2009051555  (AKADEMISCH ZIEKENHUIS LEIDEN [NL], et al);
 [X]WO2014096015  (HOFFMANN LA ROCHE [CH], et al);
by applicantEP0659439
 EP0659437
 EP1396501
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.